Alembic Pharma Q2 Profit Rises 81% to ₹335 Crore
Alembic Pharma, an Indian drug maker, reported that its net profit for the July to September quarter rose 81% to ₹335 crore. The company said its US business grew on strong sales volume and new product launches. It also said it sees growing interest in its existing branded products in the United States.
Context
Context: Alembic is an Indian pharmaceutical company that sells generic medicines abroad, and the United States is one of its biggest markets. Q2 refers to the second quarter of the financial year, which runs from July to September for Indian companies.
Burning Potato score: 54%